Bio Solution Co.,Ltd. (KOSDAQ:086820)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,400
+330 (2.98%)
At close: Apr 27, 2026
22.14%
Market Cap 295.98B
Revenue (ttm) 15.20B
Net Income (ttm) 273.36M
Shares Out 25.80M
EPS (ttm) 11.00
PE Ratio 1,082.73
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 438,256
Average Volume 175,374
Open 11,070
Previous Close 11,070
Day's Range 10,770 - 11,900
52-Week Range 7,130 - 13,450
Beta 0.07
RSI 50.28
Earnings Date May 15, 2026

About Bio Solution

Bio Solution Co.,Ltd. develops, manufactures, and sells cell therapy products worldwide. The company offers CartiLife, an autologous chondrocyte cell-based therapy for the restoration of symptomatic and structural complications caused by articular cartilage defects; KeraHeal-Allo, a thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product to promote re-epithelialization of deep 2nd-degree burn wounds; and KeraHeal, an autologous spray-type keratinocyte cell-based therapy for skin wounds. It also provides reconstructed human mic... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 086820
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.